News for Bachem Holding AG (BFEHF)

Published at

Feb 28, 2025 8:00 PM

by gurufocus.com

positive

positive

Bachem Holding AG (BCHMF) (Q4 2024) Earnings Call Highlights: Surpassing Financial Goals Amid Expansion and Sustainability Efforts

Release Date: February 27, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Bachem Holdi

BFEHF BANB.SW 0QND.L

Read more →
Published at

Feb 28, 2025 7:12 PM

by gurufocus.com

neutral

neutral

Full Year 2024 Bachem Holding AG Earnings Call Transcript

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NBANB.S - Bachem Holding AGFull Year 2024 Bachem Holding AG Earnings CallFeb 27, 2025 / 10:00AM

BFEHF BANB.SW 0QND.L

Read more →
Published at

Feb 18, 2025 7:23 AM

by manilatimes.net

neutral

neutral

Basilea reports strong 2024 full-year results with significant increase in revenue, profit and operating cash flow

**media[542809]**

BFEHF BANB.SW 0QND.L

Read more →
Published at

Oct 9, 2024 9:11 PM

by gurufocus.com

positive

positive

Bachem Holding AG (BCHMF) (Q2 2024) Earnings Call Highlights: Solid EBITDA Growth Amidst Flat Sales

Sales: CHF240.3 million, flat and 1.3% increase in local currencies.EBITDA: CHF55.5 million, a 5.6% increase in Swiss francs and 8.7% in local currencies.EBITD

BFEHF BANB.SW 0QND.L

Read more →
Published at

Oct 9, 2024 7:19 PM

by gurufocus.com

positive

positive

Half Year 2024 Bachem Holding AG Earnings Call Transcript

Jul 25, 2024 / NTS GMTDaniel Grotzky - Bachem Holding AG - Head - Group Communications Welcome to the half-year results call of Bachem. A few housekeeping rules

BFEHF BANB.SW 0QND.L

Read more →
Published at

Sep 27, 2024 2:00 PM

by globenewswire.com

mixed

mixed

Peptide Therapeutics Market to Witness 5.94% CAGR by 2031 | SkyQuest Technology

Peptide Therapeutics Market size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period...

ZLDPF ZEAL AMGN.MX AMGN.BA AMGN AMG.DE TKPHF TAKP34.SA TAKN.MX TAK PTGX 4502.T 4502.S 0A87.L ZEG.DE PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NVON.MX NVO NOVOBN.MX NOVN.SW NOVC.DE NOVA.DE NONOF N1VS34.SA MRKD.BA MRK.SN MRK.PA MRK.MX MRK LLY.MX LLY.DE LLY.BA LLY LILY34.SA IPSEY IPNN.MX IPN.PA BRM.DE BMYB34.SA BMY.MX BMY.BA BMY BFEHF BANB.SW AZNN.MX AZNCF AZN.L AZN 6MK.DE 0TDD.L 0QND.L 0Q1G.L 0K9E.L 0A4J.L

Read more →
Published at

Aug 27, 2024 1:00 PM

by globenewswire.com

positive

positive

Cosmetic Peptide Synthesis Market is Anticipated to Reach US$ 425.6 Million by 2034, Growing at a 5.7% CAGR | Fact.MR Report

Rising Use of Cosmetic Peptide Synthesis Products in Premium Anti-aging Formulations Due to Their Ability to Boost Collagen Production....

BFFAF BFEHF BASN.MX BASFY BASF.MI BASF.BD BASA.DE BAS.DE BANB.SW 0QND.L

Read more →
Published at

Jul 25, 2024 4:48 PM

by seekingalpha.com

neutral

neutral

Bachem Holding AG reports 1H results

Bachem Holding AG reports slight sales growth in the first half of 2024 and confirms outlook for full year.

BFEHF BANB.SW 0QND.L

Read more →
Published at

Jul 14, 2024 6:16 PM

by insidermonkey.com

positive

positive

30 Wealthiest People in Switzerland

Switzerland ranks among the top economies by GDP per capita ranking in the world, standing at $92,000 as of 2022.

UBSN.MX UBSGEE.SW UBSGE.SW UBSG34.SA UBSG.SW UBS JNJ DJNJ3.BA DJNJ2.BA BFEHF BANB.SW 0QND.L

Read more →
Published at

May 8, 2024 4:01 PM

by seekingalpha.com

negative

negative

Bachem Holding AG goes ex dividend tomorrow (Pink Limited Info:BCHMY)

Bachem Holding AG (BCHMY) had declared $0.0348/share dividend, Payable May 14; for shareholders of record May 10; ex-div May 9. See BCHMY Dividend Scorecard, Yi

BFEHF BANB.SW 0QND.L

Read more →
Published at

Nov 20, 2023 12:00 PM

by globenewswire.com

positive

positive

Peptide Synthesis Market revenue to reach USD 6 Billion by 2035, says Research Nester

Key peptide synthesis market players include Bachem Holding AG, Biotage, AAPP Tec, CEM Corporation ProteoGenix, GenScript, and Thermo Fisher Scientific...

TMO.MX TMO BFEHF BANB.SW 0R0H.L 0QND.L

Read more →
Published at

Jun 1, 2023 11:45 PM

by prnewswire.com

mixed

mixed

Peptide Therapeutics Global Market Report 2023: Increase in the Prevalence of Chronic Diseases Drives Growth

/PRNewswire/ -- The

TKPHF TAKP34.SA TAKN.MX TAK NVON.MX NVO NOVOBN.MX NOVC.DE NOVA.DE NONOF BFEHF BANB.SW ARCH.V ACHFF 4502.T 4502.S 0TDD.L 0QND.L 0A87.L ZEG.DE PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE NVSN.MX NVSEF NVSD.BA NVS NOVN.SW N1VS34.SA BRM.DE BMYB34.SA BMY.MX BMY.BA BMY AZNN.MX AZNCF AZN.L AZN AMGN.MX AMGN.BA AMGN AMG.DE 0K9E.L 0A4J.L

Read more →
Published at

May 31, 2023 4:00 AM

by globenewswire.com

mixed

mixed

Peptide Therapeutics Market to exceed USD 92 billion by 2032, Says Graphical Research Powered by GMI

Peptide therapeutics industry is anticipated to register 6.9% CAGR between 2023 and 2032 due to increasing investments in R&D of novel drugs and...

PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE LLY.MX LLY.DE LLY.BA LLY LILY34.SA BFEHF BANB.SW 0QND.L 0Q1G.L ZEG.DE GSK.L GSK GS7.DE GLAXF AZNN.MX AZNCF AZN.L AZN AMGN.MX AMGN.BA AMGN AMG.DE 0A4J.L

Read more →
Published at

Mar 6, 2023 8:30 PM

by prnewswire.com

mixed

mixed

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics

/PRNewswire/ -- The "Active Pharmaceutical Ingredients (API) Global Market - Forecast To 2029" & "Pharmaceutical Excipients Global Market - Forecast To 2029"...

PRGON.MX PRGO.TA PRGO P1RG34.SA JNJ IBIO DJNJ3.BA DJNJ2.BA ABBV34.SA ABBV.MX ABBV.BA ABBV 8098.T 4AB.DE 4548.T 271980.KS 0Y5E.L ZEG.DE WXXWY WXIBF WUXIF WUXAY VENUSREM.NS VENUSREM.BO TMO.MX TMO TEVJF TEVA.TA TEVA PRTK PFED.BA PFECL.SN PFE.SN PFE.MX PFE.DE PFE LZAGY LZAGF LONNN.MX LONN.SW LCI EVERESTO.BO CTLT CIPLA.NS CIPLA.BO BFFAF BFEHF BASN.MX BASFY BASF.MI BASF.BD BASA.DE BAS.DE BANB.SW AZNN.MX AZNCF AZN.L AZN 603259.SS 2359.HK 2269N.MX 1795.TW 1701.TW 0R0H.L 0QNO.L 0QND.L 0A4J.L 068270.KS TKPHF TAKP34.SA TAKN.MX TAK SUNPHARMA-BL.NS SGFEF SFZN.SW LLY.MX LLY.DE LLY.BA LLY LILY34.SA IDP.DE GSK.L GSK GS7.DE GLAXF GLAND.NS GLAND.BO GIS.DE GILDD.BA GILD.MX GILD EVKIY EVKIF EVK.DE ESALY ESALF ECR.MC DNPUF BRM.DE BMYB34.SA BMY.MX BMY.BA BMY BMRN BIOCON.NS BIOCON.BO BIIBD.BA BIIBCL.SN BIIB.SN BIIB.MX BIIB.BA BIIB AMRX AMC.DE ALB.MX ALB A1LB34.SA 4746.TW 4577.T 4523.T 4506.T 4502.T 4502.S 4142.TW 207940.KS 0QQO.L 0Q1G.L 0HNC.L 0HC7.L 0A87.L 041910.KQ

Read more →
Published at

Jan 31, 2023 5:40 PM

by prnewswire.com

neutral

neutral

At 7.5% CAGR, Global Peptide Synthesis Market Size & Share to Surpass US$ 845.68 million By 2028 | Peptide Synthesis Industry Trends, Share, Growth, Value, Analysis & Forecast Report By Facts and Fact

/PRNewswire/ -- As per Facts and Factors study, The global Peptide Synthesis market size was estimated to be worth roughly USD 509.74 million in 2021 and is...

MLAB KANKF GNNSF BITGF BFEHF BANB.SW 4118.T 196300.KQ 1548.HK 0QND.L

Read more →
Published at

Aug 2, 2022 11:45 AM

by prnewswire.com

mixed

mixed

Nucleic Acid Therapeutics CDMO Market worth $4.69 Bn by 2030 - Exclusive Report by InsightAce Analytic

/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Nucleic Acid Therapeutics CDMO Market By Technology...

SYNGENE.NS SYNGENE.BO AJINY AJINF A1GI34.SA A.MX A 2802.T 0HAV.L TMO.MX TMO QIAN.MX QIA.DE QGEN DHR.MX DHR DHER34.SA DAP.DE 0R2B.L 0R0H.L BFEHF BANB.SW 6568.T 4114.T 0QND.L

Read more →
Published at

Jan 19, 2022 4:30 PM

by prnewswire.com

mixed

mixed

Global Peptide Synthesis Market (2021 to 2026) - Development of Personalized Medicines Presents Opportunities

/PRNewswire/ -- The "Global Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer),...

SYNGENE.NS SYNGENE.BO MLAB KANKF GNNSF BITGF BFEHF BANB.SW 4118.T 196300.KQ 1548.HK 0QND.L

Read more →
Published at

Jan 4, 2022 3:30 AM

by prnewswire.com

mixed

mixed

Leuprolide Acetate Market to Record 10.42% Y-O-Y Growth Rate in 2022 |Evolving Opportunities with AbbVie Inc. & Astellas Pharma Inc. | 17000+ Technavio Reports

/PRNewswire/ -- Technavio's latest research report on the Leuprolide Acetate Market offers a comprehensive analysis on new product launches, the latest trends,...

BFEHF BANB.SW ALPMY ALPMF ABBV34.SA ABBV.MX ABBV.BA ABBV 4AB.DE 4503N.MX 1513.HK 0QND.L 000513.SZ SUNPHARMA-BL.NS

Read more →